These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 25234806)

  • 1. Dissecting the genetics of chronic mucus hypersecretion in smokers with and without COPD.
    Dijkstra AE; Boezen HM; van den Berge M; Vonk JM; Hiemstra PS; Barr RG; Burkart KM; Manichaikul A; Pottinger TD; Silverman EK; Cho MH; Crapo JD; Beaty TH; Bakke P; Gulsvik A; Lomas DA; Bossé Y; Nickle DC; Paré PD; de Koning HJ; Lammers JW; Zanen P; Smolonska J; Wijmenga C; Brandsma CA; Groen HJ; Postma DS;
    Eur Respir J; 2015 Jan; 45(1):60-75. PubMed ID: 25234806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility to chronic mucus hypersecretion, a genome wide association study.
    Dijkstra AE; Smolonska J; van den Berge M; Wijmenga C; Zanen P; Luinge MA; Platteel M; Lammers JW; Dahlback M; Tosh K; Hiemstra PS; Sterk PJ; Spira A; Vestbo J; Nordestgaard BG; Benn M; Nielsen SF; Dahl M; Verschuren WM; Picavet HS; Smit HA; Owsijewitsch M; Kauczor HU; de Koning HJ; Nizankowska-Mogilnicka E; Mejza F; Nastalek P; van Diemen CC; Cho MH; Silverman EK; Crapo JD; Beaty TH; Lomas DA; Bakke P; Gulsvik A; Bossé Y; Obeidat M; Loth DW; Lahousse L; Rivadeneira F; Uitterlinden AG; Hofman A; Stricker BH; Brusselle GG; van Duijn CM; Brouwer U; Koppelman GH; Vonk JM; Nawijn MC; Groen HJ; Timens W; Boezen HM; Postma DS;
    PLoS One; 2014; 9(4):e91621. PubMed ID: 24714607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for chronic mucus hypersecretion in individuals with and without COPD: influence of smoking and job exposure on CMH.
    Dijkstra AE; de Jong K; Boezen HM; Kromhout H; Vermeulen R; Groen HJ; Postma DS; Vonk JM
    Occup Environ Med; 2014 May; 71(5):346-52. PubMed ID: 24642640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex-Based Genetic Association Study Identifies CELSR1 as a Possible Chronic Obstructive Pulmonary Disease Risk Locus among Women.
    Hardin M; Cho MH; Sharma S; Glass K; Castaldi PJ; McDonald ML; Aschard H; Senter-Sylvia J; Tantisira K; Weiss ST; Hersh CP; Morrow JD; Lomas D; Agusti A; Bakke P; Gulsvik A; O'Connor GT; Dupuis J; Hokanson J; Crapo JD; Beaty TH; Laird N; Silverman EK; DeMeo DL;
    Am J Respir Cell Mol Biol; 2017 Mar; 56(3):332-341. PubMed ID: 27854507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. microRNA-mRNA regulatory networks underlying chronic mucus hypersecretion in COPD.
    Tasena H; Faiz A; Timens W; Noordhoek J; Hylkema MN; Gosens R; Hiemstra PS; Spira A; Postma DS; Tew GW; Grimbaldeston MA; van den Berge M; Heijink IH; Brandsma CA
    Eur Respir J; 2018 Sep; 52(3):. PubMed ID: 30072506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limited overlap in significant hits between genome-wide association studies on two airflow obstruction definitions in the same population.
    van der Plaat DA; Vonk JM; Lahousse L; de Jong K; Faiz A; Nedeljkovic I; Amin N; van Diemen CC; Brusselle GG; Bossé Y; Brandsma CA; Hao K; Paré PD; van Duijn CM; Postma DS; Boezen HM
    BMC Pulm Med; 2019 Mar; 19(1):58. PubMed ID: 30845926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci.
    Pillai SG; Ge D; Zhu G; Kong X; Shianna KV; Need AC; Feng S; Hersh CP; Bakke P; Gulsvik A; Ruppert A; Lødrup Carlsen KC; Roses A; Anderson W; Rennard SI; Lomas DA; Silverman EK; Goldstein DB;
    PLoS Genet; 2009 Mar; 5(3):e1000421. PubMed ID: 19300482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased human Ca²⁺-activated Cl⁻ channel 1 expression and mucus overproduction in airway epithelia of smokers and chronic obstructive pulmonary disease patients.
    Iwashita H; Fujimoto K; Morita S; Nakanishi A; Kubo K
    Respir Res; 2012 Jun; 13(1):55. PubMed ID: 22731784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Presence of Chronic Mucus Hypersecretion across Adult Life in Relation to Chronic Obstructive Pulmonary Disease Development.
    Allinson JP; Hardy R; Donaldson GC; Shaheen SO; Kuh D; Wedzicha JA
    Am J Respir Crit Care Med; 2016 Mar; 193(6):662-72. PubMed ID: 26695373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNAseq analysis of bronchial epithelial cells to identify COPD-associated genes and SNPs.
    Yeo J; Morales DA; Chen T; Crawford EL; Zhang X; Blomquist TM; Levin AM; Massion PP; Arenberg DA; Midthun DE; Mazzone PJ; Nathan SD; Wainz RJ; Nana-Sinkam P; Willey PFS; Arend TJ; Padda K; Qiu S; Federov A; Hernandez DR; Hammersley JR; Yoon Y; Safi F; Khuder SA; Willey JC
    BMC Pulm Med; 2018 Mar; 18(1):42. PubMed ID: 29506519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of vitamin D binding protein variants with chronic mucus hypersecretion in Iceland.
    Laufs J; Andrason H; Sigvaldason A; Halapi E; Thorsteinsson L; Jónasson K; Söebech E; Gislason T; Gulcher JR; Stefansson K; Hakonarson H
    Am J Pharmacogenomics; 2004; 4(1):63-8. PubMed ID: 14987123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs Associated with Chronic Mucus Hypersecretion in COPD Are Involved in Fibroblast-Epithelium Crosstalk.
    Tasena H; Timens W; van den Berge M; van Broekhuizen J; Kennedy BK; Hylkema MN; Brandsma CA; Heijink IH
    Cells; 2022 Feb; 11(3):. PubMed ID: 35159335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smoking induces shifts in cellular composition and transcriptome within the bronchial mucus barrier.
    Rathnayake SNH; Ditz B; van Nijnatten J; Sadaf T; Hansbro PM; Brandsma CA; Timens W; van Schadewijk A; Hiemstra PS; Ten Hacken NHT; Oliver B; Kerstjens HAM; van den Berge M; Faiz A
    Respirology; 2023 Feb; 28(2):132-142. PubMed ID: 36414410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a chronic obstructive pulmonary disease genetic determinant that regulates HHIP.
    Zhou X; Baron RM; Hardin M; Cho MH; Zielinski J; Hawrylkiewicz I; Sliwinski P; Hersh CP; Mancini JD; Lu K; Thibault D; Donahue AL; Klanderman BJ; Rosner B; Raby BA; Lu Q; Geldart AM; Layne MD; Perrella MA; Weiss ST; Choi AM; Silverman EK
    Hum Mol Genet; 2012 Mar; 21(6):1325-35. PubMed ID: 22140090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sulfatase modifying factor 1 (SUMF1) is associated with Chronic Obstructive Pulmonary Disease.
    Weidner J; Jarenbäck L; de Jong K; Vonk JM; van den Berge M; Brandsma CA; Boezen HM; Sin D; Bossé Y; Nickle D; Ankerst J; Bjermer L; Postma DS; Faiz A; Tufvesson E
    Respir Res; 2017 May; 18(1):77. PubMed ID: 28464818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-Wide Association Study Identification of Novel Loci Associated with Airway Responsiveness in Chronic Obstructive Pulmonary Disease.
    Hansel NN; Paré PD; Rafaels N; Sin DD; Sandford A; Daley D; Vergara C; Huang L; Elliott WM; Pascoe CD; Arsenault BA; Postma DS; Boezen HM; Bossé Y; van den Berge M; Hiemstra PS; Cho MH; Litonjua AA; Sparrow D; Ober C; Wise RA; Connett J; Neptune ER; Beaty TH; Ruczinski I; Mathias RA; Barnes KC;
    Am J Respir Cell Mol Biol; 2015 Aug; 53(2):226-34. PubMed ID: 25514360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common and Rare Variants Genetic Association Analysis of Cigarettes per Day Among Ever-Smokers in Chronic Obstructive Pulmonary Disease Cases and Controls.
    Lutz SM; Frederiksen B; Begum F; McDonald MN; Cho MH; Hobbs BD; Parker MM; DeMeo DL; Hersh CP; Ehringer MA; Young K; Jiang L; Foreman MG; Kinney GL; Make BJ; Lomas DA; Bakke P; Gulsvik A; Crapo JD; Silverman EK; Beaty TH; Hokanson JE;
    Nicotine Tob Res; 2019 May; 21(6):714-722. PubMed ID: 29767774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining Chronic Mucus Hypersecretion Using the CAT in the SPIROMICS Cohort.
    Stott-Miller M; Müllerová H; Miller B; Tabberer M; El Baou C; Keeley T; Martinez FJ; Han M; Dransfield M; Hansel NN; Cooper CB; Woodruff P; Ortega VE; Comellas AP; Paine Iii R; Kanner RE; Anderson W; Drummond MB; Kim V; Tal-Singer R; Lazaar AL
    Int J Chron Obstruct Pulmon Dis; 2020; 15():2467-2476. PubMed ID: 33116463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective-component compatibility of Bufei Yishen formula II inhibits mucus hypersecretion of chronic obstructive pulmonary disease rats by regulating EGFR/PI3K/mTOR signaling.
    Li J; Ma J; Tian Y; Zhao P; Liu X; Dong H; Zheng W; Feng S; Zhang L; Wu M; Zhu L; Liu S; Zhao D
    J Ethnopharmacol; 2020 Jul; 257():112796. PubMed ID: 32344236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CHRNA3/5, IREB2, and ADCY2 are associated with severe chronic obstructive pulmonary disease in Poland.
    Hardin M; Zielinski J; Wan ES; Hersh CP; Castaldi PJ; Schwinder E; Hawrylkiewicz I; Sliwinski P; Cho MH; Silverman EK
    Am J Respir Cell Mol Biol; 2012 Aug; 47(2):203-8. PubMed ID: 22461431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.